Evidence map›Paper›PMID 35866155›Full record

ArticleJBMR plus2022

Interspecies Single-Cell RNA-Seq Analysis Reveals the Novel Trajectory of Osteoclast Differentiation and Therapeutic Targets.

Yasunori Omata, Hiroyuki Okada, Steffen Uebe, Naohiro Izawa, Arif B Ekici, Kerstin Sarter, Taku Saito, Georg Schett, Sakae Tanaka, Mario M Zaiss

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in JBMR plus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Cell cycle checkpoint factor p15Scientific reports · 2025
    Article
  7. The ontogeny of synovial tissue macrophages.Frontiers in immunology · 2025
    Review
  8. Practical Compass of Single-Cell RNA-Seq Analysis.Current osteoporosis reports · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Yasunori OmataDepartment of Internal Medicine 3, Rheumatology and Immunology Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen Erlangen Germany.ORCID https://orcid.org/0000-0002-8912-7483
Hiroyuki OkadaDepartment of Orthopaedic Surgery, Faculty of Medicine The University of Tokyo Tokyo Japan.ORCID https://orcid.org/0000-0003-4217-1548
Steffen UebeInstitute of Human Genetics University of Hospital, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) Erlangen Germany.
Naohiro IzawaDepartment of Orthopaedic Surgery, Faculty of Medicine The University of Tokyo Tokyo Japan.
Arif B EkiciInstitute of Human Genetics University of Hospital, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) Erlangen Germany.
Kerstin SarterDepartment of Internal Medicine 3, Rheumatology and Immunology Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen Erlangen Germany.
Taku SaitoDepartment of Orthopaedic Surgery, Faculty of Medicine The University of Tokyo Tokyo Japan.
Georg SchettDepartment of Internal Medicine 3, Rheumatology and Immunology Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen Erlangen Germany.ORCID https://orcid.org/0000-0001-8740-9615
Sakae TanakaDepartment of Orthopaedic Surgery, Faculty of Medicine The University of Tokyo Tokyo Japan.ORCID https://orcid.org/0000-0001-9210-9414
Mario M ZaissDepartment of Internal Medicine 3, Rheumatology and Immunology Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen Erlangen Germany.ORCID https://orcid.org/0000-0003-3844-1664
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone turnover is finely tuned by cells in the bone milieu, including osteoblasts, osteoclasts, and osteocytes. Osteoclasts are multinucleated giant cells with a bone-resorbing function that play a critical role in regulating skeletal homeostasis. Osteoclast differentiation is characterized by dramatic changes in morphology and gene expression following receptor activator of nuclear factor-kappa-Β ligand (RANKL) stimulation. We performed single-cell RNA-sequencing analyses of human and murine osteoclast-lineage cells (OLCs) and found that OLCs in the mitotic phase do not differentiate into mature osteoclasts. We also identified a guanosine triphosphatase (GTPase) family member, RAB38, as a highly expressed molecule in both human and murine osteoclast clusters;

Indexed as

ChIP‐SEQUENCINGHISTONE MODIFICATIONOSTEOCLASTRAB38SINGLE‐CELL RNA‐SEQUENCING

Identifiers

PMID35866155
PMCPMC9289986
OpenAlexW4224300887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.